
Confirm the dosage form
Review the exact formulation and package for these two entries. Their names do not establish tablets or capsules.
Explore pharmacy listings
Review standalone anastrozole listings by amount and dosage form. Confirm the exact preparation, pharmacy labeling and account availability before ordering.
Already approved? Sign in to see products and pricing for your practice.
Three Optimal entries name 0.25 mg, 0.5 mg and 1 mg. Only the 1 mg source entry explicitly identifies a tablet.
3 source entries. Open a pharmacy to review its listings. Repeated or similar names do not establish distinct products or current availability.
| Source preparation / review note | Listed amount / strength | Package |
|---|---|---|
| Anastrozole 0.25mgConfirm dosage form and package | 0.25 mg | Not specified — confirm |
| Anastrozole 0.5mgConfirm dosage form and package | 0.5 mg | Not specified — confirm |
| ANASTROZOLE 1 MG TabletTablet explicitly listed; confirm manufacturer and package | 1 mg | Not specified — confirm |
Review the exact product with the responsible pharmacy before submitting an order.
Complete practice and account review to get started.
Review the preparation, pharmacy information and account pricing.
Confirm your cart, order details and applicable requirements.
Use saved carts and order history for repeat purchasing.
Participating pharmacies retain prescription review, dispensing and fulfillment responsibilities.
The treating clinician determines suitability and prescribing. Review the exact product’s labeling and pharmacy information.
Anastrozole is an aromatase inhibitor. MedlinePlus describes its use in certain breast cancer treatment settings; category placement does not establish an approved indication for another use.
MedlinePlus notes that anastrozole can reduce bone density and requires review of other medicines and medical history. The clinician should assess the exact product, intended use and relevant monitoring. MedlinePlus: anastrozole information
Confirm the regulatory status of the exact preparation. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
This page covers the three standalone anastrozole entries. The listed testosterone cypionate/anastrozole combination is covered on the Testosterone product page and requires its own formulation review.
This page represents 3 source entries. Some names may overlap; confirm the exact product and current availability through your approved account.
No. Product amounts, concentrations and package quantities describe different specifications. The clinician and dispensing pharmacy determine the prescription and instructions.
Interchangeability is not established by a shared ingredient name, matching concentration or release abbreviation. Review each complete formulation and label.
No approval status is established by catalog inclusion. Compounded preparations are not FDA-approved. Confirm the exact product and regulatory status with the pharmacy.
Ordering and account pricing are available to verified, approved clinic accounts. Patients should discuss prescriptions and treatment with their clinician.
Review the current ingredient list, strength units, dosage form, route, release characteristics, package, availability, storage and applicable pharmacy requirements.
Email info@corelinkpharm.com for platform and account questions. Contact the pharmacy for product-specific information.
Start with account access. Keep product review, pricing and ordering together.